Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2012 1
2014 3
2015 5
2016 8
2017 8
2018 6
2019 9
2020 18
2021 16
2022 13
2023 15
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

96 results

Results by year

Filters applied: . Clear all
Page 1
Epidemiology, Staging, and Management of Multiple Myeloma.
Padala SA, Barsouk A, Barsouk A, Rawla P, Vakiti A, Kolhe R, Kota V, Ajebo GH. Padala SA, et al. Among authors: kota v. Med Sci (Basel). 2021 Jan 20;9(1):3. doi: 10.3390/medsci9010003. Med Sci (Basel). 2021. PMID: 33498356 Free PMC article. Review.
Bosutinib versus imatinib for newly diagnosed chronic phase chronic myeloid leukemia: final results from the BFORE trial.
Brümmendorf TH, Cortes JE, Milojkovic D, Gambacorti-Passerini C, Clark RE, le Coutre P, Garcia-Gutierrez V, Chuah C, Kota V, Lipton JH, Rousselot P, Mauro MJ, Hochhaus A, Hurtado Monroy R, Leip E, Purcell S, Yver A, Viqueira A, Deininger MW; BFORE study investigators. Brümmendorf TH, et al. Among authors: kota v. Leukemia. 2022 Jul;36(7):1825-1833. doi: 10.1038/s41375-022-01589-y. Epub 2022 May 28. Leukemia. 2022. PMID: 35643868 Free PMC article. Clinical Trial.
Role of indoleamine 2,3-dioxygenase in acute myeloid leukemia.
Sobash PT, Kolhe R, Karim NA, Guddati AK, Jillella A, Kota V. Sobash PT, et al. Among authors: kota v. Future Oncol. 2020 Dec;16(36):3085-3094. doi: 10.2217/fon-2019-0642. Epub 2020 Sep 25. Future Oncol. 2020. PMID: 32976029 Review.
Volasertib for AML: clinical use and patient consideration.
Hao Z, Kota V. Hao Z, et al. Among authors: kota v. Onco Targets Ther. 2015 Jul 17;8:1761-71. doi: 10.2147/OTT.S60762. eCollection 2015. Onco Targets Ther. 2015. PMID: 26229484 Free PMC article. Review.
Survival of TP53-mutated acute myeloid leukemia patients receiving allogeneic stem cell transplantation after first induction or salvage therapy: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND).
Badar T, Atallah E, Shallis R, Saliba AN, Patel A, Bewersdorf JP, Grenet J, Stahl M, Duvall A, Burkart M, Palmisiano N, Bradshaw D, Kubiak M, Dinner S, Goldberg AD, Abaza Y, Murthy GSG, Kota V, Litzow MR. Badar T, et al. Among authors: kota v. Leukemia. 2023 Apr;37(4):799-806. doi: 10.1038/s41375-023-01847-7. Epub 2023 Feb 18. Leukemia. 2023. PMID: 36807649
Mortality trends in sickle cell patients.
Cintron-Garcia J, Ajebo G, Kota V, Guddati AK. Cintron-Garcia J, et al. Among authors: kota v. Am J Blood Res. 2020 Oct 15;10(5):190-197. eCollection 2020. Am J Blood Res. 2020. PMID: 33224563 Free PMC article.
96 results